<DOC>
	<DOCNO>NCT02271919</DOCNO>
	<brief_summary>Objectives : The goal clinical research study test two therapy may help people quit smoke determine one effective . The two therapy Chantix ( varenicline ) combination nicotine patch nicotine lozenge . For subject achieve smoke abstinence 6 week , objective determine effective continue therapy , change therapy augment current therapy increase dose . Aim 1 : To estimate main effect varenicline 2mg ( VAR ) nicotine patch + lozenge ( NPL ) smoker remain medication throughout trial . Aim 2 : To estimate probability abstinence twelve week function treatment assignment six week ( augmentation ) moderate initial treatment assignment ( i.e . baseline ) . Aim 3 : To estimate probability abstinence twelve week function treatment assignment six week ( switch ) moderate initial treatment assignment ( i.e . baseline ) . Aim 4 : To estimate probability treatment continuation , switch , augmentation confers benefit conditional upon fail quit initial treatment nicotine patch + lozenge ( NPL ) six week . Aim 5 : To estimate probability treatment continuation , switch , augmentation confers benefit conditional upon fail quit initial treatment VAR six week .</brief_summary>
	<brief_title>Varenicline Combined Nicotine Replacement Therapy ( NRT ) Smoking Cessation</brief_title>
	<detailed_description>Project STAR Pilot : Study Groups : Weeks 1-6 : If find eligible take part study , randomly assign ( roll dice ) 1 2 study group . This do one know one study group well , , bad group . You equal chance assign either group . - If Group 1 , receive varenicline . - If Group 2 , receive nicotine patch lozenge . Weeks 7-12 : If quit smoking , stay group assign first 6 week study . If quit smoking , 6 week study , randomly assign ( roll dice ) 1 3 new study group . You equal chance assign Groups 3 , 4 , 5 . - If Group 3 , continue drug ( varenicline nicotine patch/lozenges ) assign begin study . - If Group 4 , switch patch lozenge receive varenicline , varenicline receive patch lozenge . - If Group 5 , receive extra dose drug assign begin study , take 1 extra dose varenicline apply 1 extra nicotine patch day . Study Drug Administration : You start take assign study drug ( ) Day 9 ( day Visit 1 ) . You take varenicline tablet mouth cup ( 8 ounce ) water eat full meal . You apply nicotine patch upper arm . You put slightly different place day avoid skin irritation . You may take patch night avoid problem sleep . You may take nicotine lozenge need throughout day . You give study diary record many cigarette smoke ( ) day study . You must return study diary unused study drug , patch , lozenge , and/or container study visit . Weeks 1-6 : On Days 9-11 , put 1 patch arm morning take 1 tablet varenicline morning . Starting Day 12 , every day take 1 tablet varenicline morning 1 tablet evening continue put 1 patch arm morning . Study Visits : At every study visit ( Days 8 , 17 , 24 , 38 , 50 , 59 , 73 ) : - You complete questionnaire several topic , include depression , suicide , smoke behavior , effect study drug . These questionnaire take 30-45 minute total complete . You may complete questionnaire verbally study staff person ( either phone person , depend visit number ) electronically computer use website administer Qualtrics . - You receive counsel quit smoking , talk possible `` trigger '' smoke strategy deal quit smoking . These session take 15 minute . At Visits 1 , 5 , 6 ( Days 8 , 50 , 59 ) : - Saliva collect routine test check cotinine level . Cotinine chemical release body break nicotine show whether much recently smoke . - Your CO level weight measure . - At Visit 1 ( already Visit 0 ) , physical exam . - At Visits 1 5 , become pregnant , urine collect pregnancy test . During first counseling session ( Visit 1 ) , set `` quit date '' stop smoke 1 week start take study drug . You quit smoke quit date . You may also set goal reduce smoke . You also give drug instruction sheet , card emergency contact information , participant manual help follow along topic discuss counsel . Visits 2 , 3 , 4 , 7 ( Days 17 , 24 , 38 , 73 ) do phone questionnaire complete either electronically phone . You complete questionnaire several topic include depression , mood , smoke behavior , effect study drug . You also ask drug may take . Each phone visit , include verbal electronic questionnaire session , take 25-45 minute . The study staff call 1 day quit date , 3 day quit date , 3 day Visit 5 , 14 day Visit 5 check progress quit smoking . Each call take 10-15 minute . Length Study : You receive study drug tablet , patch , lozenges 12 week . You take study early doctor think best interest unable follow study direction . Your participation study follow-up visit . End-of-Treatment Visit ( Visit 8/Day 94 ) : After finish take study drug , follow test procedure perform : - Your CO level weight measure . - Blood ( 2 teaspoon ) draw check liver kidney function . - Saliva collected measure cotinine level . - You complete questionnaire complete regular study visit . - You receive counsel quit smoking . - If become pregnant , urine collect pregnancy test . Follow-Up Visits ( Visits 9 10 ) : At 3 6 month stop smoke , follow test procedure perform : - Your CO level weight measure . - Saliva collected measure cotinine level . - You complete questionnaire complete regular study visit . Project STAR : Study Groups : Weeks 1-6 : If find eligible take part study , randomly assign ( flip coin ) 1 2 study group first 6 week study . This do one know one study group well , , bad group . You equal chance assign either group . - Participants Group 1 receive varenicline tablet , placebo patch , placebo lozenge . A placebo drug . It look like study drug design treat disease illness . It design compare study drug learn study drug real effect . - Participants Group 2 receive placebo tablet , nicotine patch , nicotine lozenge . You also physical exam Week 1 one screening . Weeks 7-12 : If quit smoking , stay group assign first 6 week study . If quit smoking , 6 week study , randomly assign ( roll dice ) 1 3 new study group . You equal chance assign Groups 3 , 4 , 5 . - Participants Group 3 continue kind tablet ( varenicline/placebo ) , patch ( nicotine/placebo ) , lozenge assign begin study . You also take extra placebo tablet even dose , apply extra placebo patch every day . - Participants Group 4 switch different active therapy . This mean take varenicline tablet ( placebo patch lozenge ) , take placebo tablet active patch lozenge . If take placebo tablet ( active patch lozenge ) , take varenicline tablet placebo patch lozenge . You also receive extra placebo tablet even dose apply extra placebo patch every day . - Participants Group 5 receive extra dose tablet ( varenicline/placebo ) assign begin study . You also apply 1 additional patch ( nicotine/placebo ) day continue take type lozenge ( active placebo ) . Participants 3 group take 6 tablet , use 2 patch , take lozenge need day 1-7 Week 7 . In Weeks 8-12 , participant take 3 tablet , use 2 patch , take lozenge need . However , neither study doctor know group assign . If need safety , study staff able find receiving . Study Drug Administration : You begin take study drug/placebo day Visit 1 . You take varenicline/placebo tablet mouth cup ( 8 ounce ) water eat full meal . You apply nicotine/placebo patch upper arm . You put slightly different place day avoid skin irritation . You may take patch night avoid problem sleep . You may take nicotine/placebo lozenge need throughout day . You give study diary record many cigarette smoke ( ) day study . You must return study diary unused study drug , patch , lozenge , and/or container study visit . Weeks 1-6 : The first 3 day study medication , put 1 patch arm morning take 1 tablet varenicline/placebo morning . Starting 4th day study medication , every day : - You take 1 tablet varenicline/placebo morning 1 tablet evening . - You continue put 1 patch arm morning . Study Visits : At every study visit ( Visits 1-7 ) : - You complete questionnaire several topic , include depression , suicide , smoke behavior , effect study drug . These questionnaire take 30-45 minute total complete . You may complete questionnaire verbally study staff person ( either phone person , depend visit number ) electronically computer use website administer Qualtrics . - You receive counsel quit smoking , talk possible `` trigger '' smoke strategy deal quit smoking . These session take 15 minute . - You ask medication take . At Visits 1 , 5 , 6 : - Urine collect routine test check cotinine anabasine level . Cotinine chemical release body break nicotine show whether much recently smoke . Anabasine show nicotine blood due nicotine replacement therapy tobacco use . - Your CO level weight measure . - At Visit 1 , study staff think need , urine collect NicAlert test . A NicAlert test well detecting level smoke CO machine . - At Visit 1 ( already Visit 0 ) , physical exam . - At Visits 1 5 , become pregnant , urine collect pregnancy test . - At Visits 5 6 , blood ( 2 teaspoon ) draw check level medication blood . During first counseling session ( Visit 1 ) , set `` quit date '' stop smoke 1 week start take study drug/placebo . You quit smoke quit date . You may also set goal reduce smoke . You also give drug instruction sheet , card emergency contact information , participant manual help follow along topic discuss counsel . Visits 2 , 3 , 4 , 7 do phone questionnaire complete either electronically phone . You complete questionnaire several topic include depression , mood , smoke behavior , effect study drug . You also ask drug may take . Each phone visit , include verbal electronic questionnaire session , take 25-45 minute . The study staff call 1 day quit date , 3 day quit date , 3 day Visit 5 , 14 day Visit 5 check progress quit smoking . Each call take 10-15 minute . Ecological Momentary Assessment ( EMA ) : EMAs use gather information relate craving mood real time natural environment . At first visit , provide smart phone device . You answer question various point everyday 84 day . The question event previous day , cigarette per day , alcohol drank , mood , sleep , motivation , take medication . These assessment take 30 minute per day complete . Length Study : You receive study drug/placebo tablet , patch , lozenges 12 week . You take study early doctor think best interest unable follow study direction . Your total study participation randomization end final followup visit approximately 6 month . Your participation study follow-up visit . End-of-Treatment Visit ( Visit 8/Day 94 ) : After finish take study drug/placebo , follow test procedure perform : - Your CO level weight measure . - Blood ( 2 teaspoon ) draw check liver kidney function . - Urine collect measure cotinine level . - You complete questionnaire complete regular study visit . - You receive counsel quit smoking . - If become pregnant , urine collect pregnancy test . Follow-Up Visits ( Visits 9 10 ) : At 3 6 month stop smoke , follow test procedure perform : - Your CO level weight measure . - Urine collect measure cotinine level . - You complete questionnaire complete regular study visit . - If do End-of-Treatment Visit , blood ( 2 teaspoon ) draw first follow-up visit . This investigational study . Varenicline , nicotine patch , nicotine lozenge FDA approve commercially available help people stop smoking . The study doctor explain study drug design work . Up 300 participant take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>1 . Age : 1875 year old 2 . Smoking 5 cigarette and/or little cigar per day , average , within 2 month precede screen visit expire carbon monoxide ( CO ) great equal 6 part per million ( ppm ) ( less equal 5 , NicAlert Strip &gt; 2 ) . 3 . Interested treatment might change smoke behavior 4 . Able follow verbal write instruction English complete aspect study 5 . Provide informed consent agree assessment study procedures 6 . Have address telephone number he/she may reach 7 . Be participant his/her household ExclusionCriteria : 1 . Within month immediately precede screen visit , use form tobacco product cigarettes little cigar 3 day within week individual refuse refrain tobacco use course study . 2 . Current enrollment plan enroll another smoking cessation program next 12 month 3 . Plan use nicotine substitute ( i.e. , OTC prescription medication smoke cessation ) smoke cessation treatment next 12 month 4 . Uncontrolled hypertension ( systolic blood pressure ; SBP great 180 diastolic blood pressure ; DBP great 110 ) 5 . History severe kidney disease ( e.g chronic acute kidney failure ) creatinine clearance 30 and/or severe liver disease liver test 4 time upper normal level 6 . Laboratory evaluation ( kidney liver ) outside normal limit potential clinical significance opinion investigator 7 . Serious unstable disease within past 3 month 8 . History ( last 3 month ) abnormal heart rhythm , cardiovascular disease ( stroke , angina , heart attack ) may result ineligibility . These condition evaluate case case basis Study Physician . 9 . Current use certain medication : ( 1 ) Smoking cessation med ( last 7 day ) , i.e. , Wellbutrin , Bupropion , Zyban , NRT , Chantix , ( 2 ) Certain medication treat depression ( last 14 day ) , i.e . MAOIs Elavil ( Amitriptyline ) , ( 3 ) A case case determination make study physician medication precautionary list , i.e . nitroglycerin , ( 4 ) Daily use opioids 30 day phone screen screen exclusionary however PRN use allow ( i.e. , 3:7 day per week le frequent , use less month 's duration . 10 . Meet criterion follow psychiatric and/or substance use disorder assess MINI International Neuropsychiatric Interview ( MINI ) : item C ( current manic hypomanic episode ) , I ( alcohol abuse Alcohol Addendumpast 6 month ; current alcohol dependence ) , J ( substance abuse Substance Abuse Addendum past 6 month ; current substance dependence ) , K ( current psychotic disorder current mood disorder psychotic feature ) . Individuals meet criterion nonexclusionary psychiatric disorder consider clinically unstable and/or unsuitable participate determine Principal Investigator and/or Study Physician . 11 . Individuals rat moderate ( 916 ) high ( 17 great ) suicidality assess Module B MINI . 12 . Psychiatric hospitalization within 1 year screening date . 13 . A positive urine pregnancy test screening period . Women two year postmenopausal , tubal ligation partial full hysterectomy subject urine pregnancy test . 14 . Pregnant , breastfeed childbearing potential protect medically acceptable , effective method birth control enrol study . Medically acceptable contraceptive include : ( 1 ) approve hormonal contraceptive ( birth control pill , patch , implant injection ) , ( 2 ) barrier method ( condom diaphragm ) use spermicide , ( 3 ) intrauterine device ( IUD ) . Contraceptive measure sell emergency use unprotected sex acceptable method routine use . 15 . History hypersensitivity allergic reaction Varenicline , NRT , component formulation ( include allergy latex ) . 16 . Any medical psychiatric condition , illness , disorder , concomitant medication could compromise participant safety treatment , determine Principal Investigator and/or Study Physician . 17 . Subject consider investigator unsuitable candidate receipt investigational drug , unstable follow throughout entire duration study 18 . Positive toxicology screen follow drug : cocaine , opiates , methadone , benzodiazepine , barbiturate , amphetamine , methamphetamine , PCP , THC . . Participants valid prescription opiate , benzodiazepine , barbiturate , amphetamine methadone exclude . b . Participants fail toxicology screen allow rescreen . If test positive , allowed return .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Cancer Prevention</keyword>
	<keyword>Tobacco Use Cessation</keyword>
	<keyword>Nicotine replacement therapy</keyword>
	<keyword>NRT</keyword>
	<keyword>Varenicline</keyword>
	<keyword>Chantix</keyword>
	<keyword>Nicotine lozenge</keyword>
	<keyword>Placebo tablet</keyword>
	<keyword>Placebo patch</keyword>
	<keyword>Questionnaire</keyword>
	<keyword>Survey</keyword>
	<keyword>Counseling</keyword>
</DOC>